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Abstract
Purpose: The purpose of this project was to evaluate provider use of hemoglobin (HgA1c)
measurement as a method of screening for Type Two Diabetes Mellitus (T2DM) per the 2015
American Diabetes Association screening guidelines in a multidisciplinary primary care clinic in
Kentucky.
Methods: A retrospective electronic medical record review was conducted in a large ambulatory
care clinic. A master list was compiled of all patients aged 45-89 years who were seen for any
reason the first week of November 2015. A total of 127 records that met inclusion criteria were
randomly selected. The proportion of patients who were appropriately screened in the past three
years with HgA1c measurement was calculated. Data was analyzed using descriptive statistics.
Results: Approximately 60% of all of the patients who met both the age and BMI screening
criteria were screened in the past three years using HgA1c. Of those patients who were screened,
3.9% met criteria for the diagnosis of diabetes, and approximately 40% met criteria for the
diagnosis of pre-diabetes based on the HgA1c results.
Conclusions: Using only the HgA1c as a method of screening, providers in this clinic
appropriately screened 60% of all patients who met the criteria of BMI and age which exceeds
the projected compliance rate in the literature.
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Introduction
Type Two Diabetes Mellitus (T2DM) is a complex chronic illness that can have lifethreatening complications. This illness requires a partnership between the healthcare provider
and the patient in order to manage the disease and prevent complications. There are several risk
factors for diabetes. The two primary risk factors of obesity and age should be used to determine
screening for diabetes. The American Diabetes Association (ADA, 2015) provides screening
recommendations for diabetes using these two risk factors as indicators. Though a number of
options for screening are available to providers, the HgA1c is the most comprehensive, reliable
and easy to use screening test. Unfortunately, not all providers are screening based upon risk
factors nor are they using the HgA1c to screen. The purpose of this project is to evaluate
provider compliance with the 2015 ADA screening guidelines in a multidisciplinary primary care
clinic in Kentucky.
Background
Diabetes is the seventh leading cause of death in the United States and affects
approximately 23.6 million people. It is estimated 25 percent of Americans have diabetes but are
undiagnosed and another 57 million are at increased risk for developing diabetes within a few
years (U.S. Department of Health and Human Services [USDHHS], 2015). In 2012 the Centers
for Disease Control and Prevention (CDC) noted the age-adjusted rate of adults diagnosed with
diabetes in Kentucky has doubled from approximately four percent 1994 to approximately ten
percent in 2012, a rate above the national average of nine percent during the same time period.
The age-adjusted rate of adults with pre-diabetes in Kentucky of approximately eight percent
was above the national average of seven percent as well (CDC, 2012).
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There are several complications of diabetes. Per the U.S. Department of Health and
Human Services (2015) diabetes can lower life expectancy by 15 years and increase the risk of
heart disease two to fourfold. It is the leading cause of lower limb amputation, adult-onset
blindness, and kidney failure. These complications may be prevented by early recognition of the
disease, lifestyle modifications, and medication management (USDHHS, 2015; ADA, 2015;
Chatterjee et al., 2010).
The cost for medical care for patients with diabetes is substantial. In 2007, the financial
burden of diabetes medical care was approximately $174 billion in the United States which
included disability and premature death (USDHHS, 2015). For Kentucky, the estimated cost of
diabetes was over three billion dollars, which included direct and indirect medical costs and
reduced productivity in 2015 (KY Department for Medicaid Services, 2015). Associated
healthcare costs are expected to increase proportionately with the number of individuals
diagnosed with diabetes and prediabetes.
Screening for T2DM leads to earlier diagnosis and interventions to prevent progression of
the disease and subsequent complications. Screening for diabetes using HgA1c (Chatterjee et al.,
2010) and fasting plasma glucose improves health outcomes (Hanna et al., 2012; The Diabetes
Prevention Program Research Group, 2005) and is cost effective (Chatterjee et al., 2010).
However, not all practitioners are using the same guidelines for screening (Sarkar, Lopez, Black
& Schillinger, 2011; Kuntz et al., 2012; Serrano, Leiferman, & Dauber, 2007). Several respected
organizations such as the ADA, Diabetes Prevention Program, US Preventive Services Task
Force (USPSTF), American Heart Association, the American College of Physicians, the
Endocrine Society, and the Veterans Health Administration, periodically publish
recommendations for screening. In 2008, the USPSTF published recommendations for screening
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individuals with hypertension as the only risk factor. In contrast, the ADA recommends
screening based on multiple risk factors.
Most organizations agree individuals greater than age 40 who are overweight or obese
should be screened for T2DM at least every three years (DPP, 2005; Siu, 2015; ADA, 2015).
Dall et al. (2014) suggested the use of the ADA screening guidelines detected significantly more
individuals with prediabetes and diabetes than the USPSTF guidelines. Such stark
inconsistencies in recommendations could lead to missed screening opportunities and delayed
diagnoses.
Recently the USPSTF published guidelines recommending screening every three years
for all individuals ages 40-70 years who are overweight or obese (Siu, 2015). The ADA (2015)
has no age limit for screening but recommends screening individuals 45 years or older who have
a BMI of 25 or greater at least every three years. More frequent screening is recommended for
individuals who have one or more risk factors including physical inactivity, ethnicity, past
medical history, family medical history, and co-morbidities such as hypertension and
hyperlipidemia (ADA, 2015).
Testing for diabetes can be done using either HgA1c level, fasting plasma glucose, or 2hour oral glucose tolerance test (ADA, 2015). The ADA (2015) guidelines state the HgA1c is
preferred because of its convenience. It provides a more accurate idea of blood glucose control
reflecting the preceding three months. It is not affected by acute factors such as illness, stress, or
recent food consumption (ADA, 2015; Degling, Rock, & Rogers, 2011). Levels may be affected
by characteristics of the individual including anemia, ethnicity, and age (ADA, 2015)
The diagnosis of diabetes or pre-diabetes can be established on the HgA1c result. Prediabetes describes individuals at an increased risk for development of diabetes. It has been
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suggested HgA1c values are strong predictors of progression to diabetes. Per the ADA (2015),
HgA1c values of 6.5% or greater are consistent with the diagnosis of diabetes. Hemoglobin A1C
values of 5.7-6.4% are consistent with the diagnosis of pre-diabetes. Zhang et al. (2010) reported
individuals with HgA1c values of 5.5-6.0% had up to a 25% chance and those with values of 6.06.5% had up to a 50% chance of developing diabetes within five years.
Purpose
The purpose of this project was to evaluate provider compliance with the 2015 ADA
screening guidelines for T2DM using HgA1c measurements in a multidisciplinary primary care
clinic in Kentucky. There were four objectives for this project. The primary objective of this
study was to determine the proportion of patients 45-89 years of age at high risk for diabetes
(BMI ≥ 25) who were screened for diabetes using HgA1c at or within the three years prior to the
sampled visit. A second objective was to determine if patients were screened at acute problem
visits or health maintenance visits. The third objective was to determine the number of acute and
health maintenance visits in the past three years where screening could have been conducted if
indicated. Lastly, this study aimed to determine whether or not patients who met screening
criteria were screened, using HgA1c, more frequently than every three years.
Methods
Study Design
This study was approved by the Institutional Review Board for Protection of Human
Subjects at the University of Kentucky and by the internal research committee at the primary
care clinic. A retrospective chart audit was conducted to determine whether patients who met
inclusion criteria were screened using HgA1c measurements in the past three years. Patients met
inclusion criteria if they were between 45-89 years old, had a BMI ≥25, and were seen the first
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week of November 2015. Patients were excluded if they had a previous diagnosis of diabetes
mellitus type 1, diabetes mellitus type 2, pre-diabetes, gestational diabetes, impaired glucose
tolerance, or impaired fasting glucose
A total of 565 patients over the age of 45 were seen during the study interval. Using the
World Health Organization (2008) guide to choosing a sample size, for a population of 565
patients, a sample of 127 patients was recommended for statistical significance. Data collected
included patient demographics, credentials of the provider who appropriately ordered a HgA1c
screening test, the HgA1c result, the visit type (acute or health maintenance), the number of
“missed opportunities”, and whether or not the patient was screened more frequently than every
three years (see Appendix A: Data Collection Table). De-identified data was collected using an
electronic data collection form (see Appendix A) and was stored using REDCap®, a secure,
password protected web-based application.
After receiving a master list of patients meeting inclusion criteria (age and BMI) who had
been seen for an acute or health maintenance visit, every fourth chart was reviewed until the goal
sample of 127 patients was met. Acute visits were included because this may be the only
opportunity to screen patients who miss health maintenance visits. It is important to note at this
clinic, providers practice under a team model. Each patient is assigned to a team consisting of an
attending, two resident physicians, and one advanced practice registered nurse. The physicians
are assigned as the primary care providers. However, the APRN is a vital part of the health care
team, seeing mostly acute sick visits, chronic disease follow-ups, and initial disease specific
visits for new patients. This model allows patients to be seen in a timely manner and improves
access to care.
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Data Analysis
Results from the retrospective electronic medical record review were analyzed using
SPSS 22 statistical software. Initially, statistical significance between provider type and
screening was anticipated. However, due to the distribution in numbers of the provider types in
the sample, this relationship could not be adequately evaluated. Therefore, descriptive statistics
including frequencies, means, and percentages were used to evaluate study objectives regarding
screening practices.
Results
Of the 595 patients who were seen during the first week of November 2015, 127 patients
who met inclusion criteria were systematically selected. This sample had an average age of 59.1
years old, with a range of 45-88 and a standard deviation of 9.6. Sixty-one percent of the sample
were females. The average BMI was 30.3 with a range of 25.0-43.6 and a standard deviation of
4.2. Fifty-two percent of the patients in the sample were considered overweight (BMI 25.0-29.9),
the remaining individuals were considered obese (BMI ≥ 30).
Table 1. Summary of Diabetes Screening using HgA1c
Variable
Were patients who met criteria (N=127)
screened?
Yes
No
Visit type of those screened (n=76)
Health Maintenance
Acute
Were patients screened more than every three
years using HgA1c?
Yes
No
A1c results of those screened (n=76):
Diabetes (HgA1c ≥6.5%)
Pre-diabetes (HgA1c 5.7-6.49%)
Normal (HgA1c <5.7%)
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n (%)
76 (60%)
51 (40%)
68(90%)
8(10%)
23(30%)
53(70%)
3(4%)
30(40%)
43(56%)

Approximately 60% (n=76) of the patients who met screening criteria were screened
using HgA1c measurement. The majority of screening occurred during a health maintenance
visit (n=68 or 90%). Of the health maintenance visits, 76% were with a physician. Acute visits
only accounted for 10% of the screenings. Of the acute visits, 62% were with an APRN.
Of those that were screened, approximately 40% met the diagnostic criteria of prediabetes with HgA1c levels between 5.7 and 6.49%. Of those individuals with prediabetes, 57%
were considered obese with a BMI of 30 or greater. There were three patients (4%) that met
diagnostic criteria for diabetes with HgA1c levels of 6.5% or greater. Of those patients with
diabetes, two thirds were obese.
Approximately 40% (n=51) of the patients who met screening criteria were not screened
using HgA1c measurement in the past three years. The individuals not screened had an average
of five acute visits and four health maintenance visits within that three-year period. Of those
screened, 30% were screened more than once in the last three years.
Discussion
In this setting more than half of patients meeting screening criteria were screened using
HgA1c measurements. The proportion of patients screened by this clinic (60%) using HgA1c is
higher than estimates in the literature of a 5-50% compliance rate for screening (Koll & Hewitt et
al., 2011, Dall et al., 2012). The actual screening rate may be higher since only one of the three
recommended screening tests was studied.
Most of the patients were screened during a health maintenance visit which is considered
standard practice. The majority of screening tests were ordered by physicians, which aligns with
the practice model of this particular clinic, as APRNs are not assigned to patients as primary care
providers and screening is not expected at acute visits. Initially there was interest in comparing
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screening rates between providers, due to the distribution in this sample, this comparison was not
possible. Though the majority of screenings were conducted at health maintenance visits, it may
be the case that acute visits are the only screening opportunities for some individuals.
There are several reasons why patients do not come in for health maintenance visits
which may include lack of time, resources, insurance, or motivation. Some individuals believe
that they do not need to see a health care provider unless they are ill. Others may be unaware of
the benefits of regular contact with a health care provider, such as screening, and the risks of not
being seen regularly. Therefore, health care providers must capitalize on opportunities when they
present themselves. Preventive services, such as screening, at acute problem visits are not ideal.
Necessary and important information about why screening is indicated, the type of screening,
possible outcomes, and follow up are diluted due to the limited allotted time. Also, patients may
not be receptive to recommendations for screening because they are focused on the acute
problem that brought them in. Research evaluating patient barriers to health maintenance visits
and potential solutions is needed.
Forty percent of the patients who met screening criteria had not been screened with
HgA1c measurement in the past three years. The patients who were not screened presented to the
clinic for five acute visits and four health maintenance visits, on average, over the past three
years. They had an average of eight visits with a physician and one visit with an APRN in the
past three years. These findings suggest that physicians had more interaction with the patients
who were not screened with HgA1c measurements. However, the provider may have screened
the patient using fasting plasma glucose as part of routine laboratory testing.
Approximately 30% of patients who were screened in this study had been screened more
than once in the past three years. This specific data was collected at the request of the clinic to
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determine whether they were screening patients inappropriately, or more often than the
recommended three-year interval. Though the ADA (2015) discouraged screening more than
every three years, there may be indications for retesting such as the development of new risk
factors or previous testing that indicated increased risk. For instance, if the patient was newly
diagnosed with hypertension or hyperlipidemia, screening would be indicated. Also, if a patient
presents with symptoms such as blurred vision, frequent urinary tract infections, frequent yeast
infections, or numbness or tingling of the extremities, screening for diabetes would be indicated
as part of the diagnostic workup. Since this study focused on BMI and age as primary risk
factors, it may not be sufficient in determining screening too frequently because other risk
factors were not considered.
Pre-diabetes was noted in 40% of the patients screened in this study. This is consistent
with the national average of 35-50% of adults having pre-diabetes, validating screening
individuals who have risk factors for diabetes (CDC, 2011). Of those patients with prediabetes,
only 57% were considered obese. Of the three patients identified as having diabetes, only two
thirds had a BMI of 30 or greater. Once individuals are screened appropriately, interventions can
be implemented to decrease the progression of pre-diabetes to diabetes.
Limitations
A major limitation of this study was the evaluation of the HgA1c as a screening method.
Though 40 percent of patients meeting the inclusion criteria were not screened, it is possible that
providers used a fasting glucose test which is part of the metabolic profile typically ordered.
However, in the electronic medical record used for this study, it was difficult to determine
whether or not the patient was fasting for these routine labs. The HgA1c measurement was the
only diabetes screening test evaluated because it is the most accurate and specific to diabetes.
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Therefore, this study may not adequately portray overall screening practices or compliance with
the screening guidelines.
There were other limitations of this study because of the design. This study did not
evaluate screening or rescreening based on risk factors other than age and BMI. Secondly, the
original objective to compare screening practices by provider type was not met because the
patients were not divided evenly by provider. Also, the practice model of the clinic setting was
not conducive to comparisons of providers as APRNs are not assigned as PCPs. Lastly, this
study did not get provider input on preferred screening method (i.e. fasting plasma glucose
versus HgA1c) which could have explained the individuals who were not screened using HgA1c.
Implications for Practice
Though the ADA has clear definitions of when and how to screen, provider compliance
with screening guidelines could use improvement. The ADA (2015) recommends HgA1c as the
screening test of choice as it is convenient and unaffected by fasting status. Also, the HgA1c is
specific to diabetes. When a provider orders this measurement, they are intentionally looking for
the presence of diabetes. Clearly, it appears that it should be the only test recommended to screen
for diabetes in the future.
Since the ADA updates recommendations for screening and diagnosing diabetes
annually, a formal educational session to review the latest updates may be useful in this and
other primary care clinics. It may also be beneficial to educate the public about risk factors for
diabetes, the importance of early detection, and available screening methods. Evaluation of
current procedures once a patient is diagnosed with diabetes or prediabetes would be helpful in
determining appropriate use of evidence-based interventions such as healthy diet, regular
physical activity, and weight loss.
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Finally, several other quality improvement questions need to be answered and evaluated.
The pros, cons, and barriers to screening at acute versus health maintenance visits should be
explored. Analysis of rescreening practices and whether they are cost effective would be useful
to improve current standards of care. Determining what processes and procedures are in place
once a provider receives results of screening tests would be helpful to ensure adequate follow up
and timely intervention. Barriers to compliance with screening guidelines and interventions to
improve compliance should be assessed as well.
Conclusion
In conclusion, diabetes is a major health issue in the United States which warrants
attention by every health provider. Screening for diabetes using an evidence-based protocol, such
as one published by the ADA, can lead to early diagnosis of diabetes and pre-diabetes.
Identification of individuals at risk for diabetes is essential for early intervention and prevention
of progression of the disease and/or complications. Despite provider adherence to the 2015 ADA
guidelines at this clinic, was approximately 60% and above national norms of 5-50% for all
screening methods, a significant percentage of patients had not been screened. Since early
detection and intervention can positively affect quality of life and health outcomes for patients,
there is reason to strive for even more improvement.
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Appendix A
Data Collection Table
Patient #

Age

BMI
reading
at this
visit

Gender

Was
HgA1C
ordered
since
turning
45 (or
in the
past 3
years)

Age of
the
patient
when
HgA1C
ordered

Has
patient
been
screened
more
often
than
every 3
years?

Acute
or
HM
visit?

1
2
3
4
5
6
7
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Hg
A1C
result

Provider
type
when
HgA1C
ordered

Total
number
of acute
visits in
the past
3 years
when no
HgA1c
done for
diagnosis

Total
number
of HM
visits in
the past
3 years
when no
HgA1c
done for
diagnosis

Number
of visits
with
APRN
in the
past 3
years
when no
HgA1c
done for
diagnosis

Number of
visits with
MD in the
past 3 years
when no
HgA1c done
for diagnosis
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